Justin Jee, MD, PhD
Thoracic Medical Oncologist
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Areas of Expertise
My Specialties
- Non-Small Cell Lung Cancer
- Neuroendocrine Lung Cancer
- Small Cell Lung Cancer
Request an Appointment
About Me
- Instructor
My goal as an oncologist is to bring hope to patients with lung cancer. My practice is informed by the latest advances in medical science, including:
- Immunotherapies (a type of treatment that uses a person’s own immune system to kill cancer cells)
- Personalized targeted therapies (a type of treatment that targets the genetic mutations in a tumor)
- Clinical trials
- Collaboration with our world-class radiation oncologists and surgeons
Read more
For patients admitted to the hospital, I work with a team of nurses, pharmacists, nurse practitioners, specialists, and the patient’s own oncologist to ensure that my patients are well cared for at an especially vulnerable point in their life.
As a physician-scientist, I research the best means by which science can improve human lives. I led an international study showing that liquid biopsies, which match patients to targeted therapies with a blood draw rather than a tumor biopsy, can extend the lives of people with aggressive non-small cell lung cancers (NSCLCs). I also led one of the first studies on the relative safety of chemotherapy in patients with cancer and COVID-19.
I currently lead the Clinical Data Mining Team at Memorial Sloan Kettering Cancer Center (MSK). This is a group of engineers, data scientists, graduate students, and postdoctoral fellows within MSK’s Computational Oncology Service and Cancer Data Science Initiative. We study novel biomarkers and integrated machine learning techniques to better reduce side effects and improve length and quality of life for our patients.
A thoracic medical oncologist is a cancer doctor who specializes in thoracic (thor-A-sik) cancers. These are cancers that have to do with the chest, including lung, tracheal (windpipe), and thymic (thymus) cancers.
My Specialties
- Non-Small Cell Lung Cancer
- Neuroendocrine Lung Cancer
- Small Cell Lung Cancer
Education
- MD New York University
- PhD New York University
Residencies
- Internal Medicine, New York Presbyterian/Columbia
Awards and Honors
- K12 Paul Calabresi Career Development Award for Clinical Oncology, NIH/MSK (2023-2026)
- Young Investigator Award, ASCO Conquer Cancer Foundation (2023)
- Scholar-in-Training Award, American Association for Cancer Research, (2023)
- Merit Award, ASCO Conquer Cancer Foundation (2021, 2023)
- T32 Investigational Cancer Therapeutics Training Program Fellow, National Institutes of Health (NIH)/Memorial Sloan Kettering Cancer Center (MSK, 2019-2022)
Fellowships
- Medical Oncology, Memorial Sloan Kettering Cancer Center
Board Certifications
- Internal Medicine
- Medical Oncology
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
PPO, HMO, DSN
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
PPO, HMO
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
New Patients
Current Patients
Contact and Location
Dr. Jee sees patients at one location.
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Jee J, Lebow ES, Yeh R, Das JP, Namakydoust A, Paik PK, Chaft JE, Jayakumaran G, Rose Brannon A, Benayed R, Zehir A, Donoghue M, Schultz N, Chakravarty D, Kundra R, Madupuri R, Murciano-Goroff YR, Tu HY, Xu CR, Martinez A, Wilhelm C, Galle J, Daly B, Yu HA, Offin M, Hellmann MD, Lito P, Arbour KC, Zauderer MG, Kris MG, Ng KK, Eng J, Preeshagul I, Victoria Lai W, Fiore JJ, Iqbal A, Molena D, Rocco G, Park BJ, Lim LP, Li M, Tong-Li C, De Silva M, Chan DL, Diakos CI, Itchins M, Clarke S, Pavlakis N, Lee A, Rekhtman N, Chang J, Travis WD, Riely GJ, Solit DB, Gonen M, Rusch VW, Rimner A, Gomez D, Drilon A, Scher HI, Shah SP, Berger MF, Arcila ME, Ladanyi M, Levine RL, Shen R, Razavi P, Reis-Filho JS, Jones DR, Rudin CM, Isbell JM, Li BT. Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer. Nat Med. 2022 Nov;28(11):2353-2363. doi: 10.1038/s41591-022-02047-z. Epub 2022 Nov 10. PMID: 36357680.
Jee, J.*; Foote, M.*; Lumish, M.*; Stonestrom, A.J.*; Wills, B.*; Narendra, V.*; Avutu, V.; Murciano-Goroff, Y.R.; Chan, J.E.; Derkach, A.; Philip, J.; Belenkaya, R.; Kerpelev, M.; Maloy, M.; Watson, A.; Fong, C.; Janjigian, Y.; Diaz Jr., L.A.; Bolton, K.; Pessin, M. Chemotherapy and Covid-19 outcomes in cancer patients. Journal of Clinical Oncology. 2020 doi:10.1200/JCO.20.01307
Jee, J.; Rasouly, A.; Shamovsky, I.; Akivis, Y.; Steinman, S.; Mishra, B.*; Nudler, E*. Rates and Mechanisms of Bacterial Mutagenesis from Maximum-Depth Sequencing. Nature. 2016. doi: 10.1038/nature18313
Visit PubMed for a full listing of Dr. Jee’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Justin Jee discloses the following relationships and financial interests:
-
MDSeq Inc
Intellectual Property Rights
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].